Selection for soluble proteins via fusion with chloramphenicol acetyltransferase.
Sieber
Volker
V
Degussa AG, Projecthouse Biotechnology, Geising, Germany.
D019677:Artificial Gene Fusion / Q000379:methods*; D001483:Base Sequence; D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics* / Q000378:metabolism; D003001:Cloning, Molecular / Q000379:methods*; D019388:Cytochrome P-450 CYP1A2 / Q000235:genetics* / Q000378:metabolism; D017931:DNA Primers; D008957:Models, Genetic; D008969:Molecular Sequence Data; D011506:Proteins / Q000235:genetics* / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D015183:Restriction Mapping; D012641:Selection, Genetic; D012995:Solubility; D012996:Solutions
D017931:DNA Primers; D011506:Proteins; D011993:Recombinant Fusion Proteins; D012996:Solutions; D019388:Cytochrome P-450 CYP1A2; D015500:Chloramphenicol O-Acetyltransferase